ARCHIVES

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

This article is from The Cancer Letter archive.

Vol. 05 No. 47 | November 23, 1979

Download PDF Visit The Full Archive

Related Articles

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

April 21, 1989

NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database

October 11, 1996

Human Genome Consortium Completes “Working Draft”.

June 30, 2000

In Brief: Search Committee Could Finish Job Weeks, Perry Says Nominations Are Being Solicited

January 11, 1980

House, Senate Meet On Appropriations Bill Differences

October 6, 1989

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011